Tech Company M&A Transactions

Modis Therapeutics Acquisition

On 8/27/2019, Modis Therapeutics was acquired by Zogenix. Purchase price was estimated to be $400 million.

Transaction Overview

Company Name
Acquired By
Announced On
Transaction Type
M&A Terms
Under the terms of the deal, subject to the satisfaction of customary closing conditions, Modis will receive an upfront payment of $250m, comprised of $175m in cash and $75m in Zogenix common stock. The acquired company is also eligible to receive additional milestone payments consisting of $100m upon receipt of U.S. Food and Drug Administration approval of MT1621 in the U.S. and $50m upon European Medicines Agency approval in Europe. Zogenix will also pay a 5% royalty on any future net sales of MT1621.

Company Information

Company Status
Acquired or Merged
Mailing Address
409 13th St. 700
Oakland, CA 94612
Email Address
Modis Therapeutics was formed in 2016 through a collaboration with academic experts in mitochondrial biology to develop disease-modifying therapies for rare genetic diseases.
Modis Therapeutics LinkedIn Company Profile
Social Media
Modis Therapeutics Company Twitter Account
Company News
Modis Therapeutics News
Modis Therapeutics on Facebook
Modis Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Joshua Grass
  Joshua Grass LinkedIn Profile  Joshua Grass Twitter Account  Joshua Grass News  Joshua Grass on Facebook
Chief Medical Officer
Joanne Quan
  Joanne Quan LinkedIn Profile  Joanne Quan Twitter Account  Joanne Quan News  Joanne Quan on Facebook
Vice President
Daniel DiPietro
  Daniel DiPietro LinkedIn Profile  Daniel DiPietro Twitter Account  Daniel DiPietro News  Daniel DiPietro on Facebook
Vice President
Stacey Harte
  Stacey Harte LinkedIn Profile  Stacey Harte Twitter Account  Stacey Harte News  Stacey Harte on Facebook
Vice President
Laurie Tsuruda
  Laurie Tsuruda LinkedIn Profile  Laurie Tsuruda Twitter Account  Laurie Tsuruda News  Laurie Tsuruda on Facebook
VP - Bus. Development
Peter Barber
  Peter Barber LinkedIn Profile  Peter Barber Twitter Account  Peter Barber News  Peter Barber on Facebook
VP - Finance
Aaron Mishel
  Aaron Mishel LinkedIn Profile  Aaron Mishel Twitter Account  Aaron Mishel News  Aaron Mishel on Facebook
VP - Manufacturing
Paul Glidden
  Paul Glidden LinkedIn Profile  Paul Glidden Twitter Account  Paul Glidden News  Paul Glidden on Facebook



Browse more venture capital transactions:

Prev: 8/26/2019: Windfall Data venture capital transaction
Next: 8/27/2019: Stylitics venture capital transaction


Share this article


Where The Data Comes From

Our team works diligently to record all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary